Table 3.
Adverse Events During Ruxolitinib Treatment
| Variables | aGVHD(n=17) | cGVHD(n=36) |
|---|---|---|
| %(Number) | %(Number) | |
| Cytopenia | 70(12) | 11(4) |
| Liver function injury | 29(5) | 8(3) |
| EBV reactivation | 12(2) | / |
| CMV reactivation | 35(6) | 3(1) |
| BKV infection | 12(2) | / |
| TB infection | 6(1) | / |
| Bacterial infection | / | 6(2) |
| PCP | / | 3(1) |
| Malignancy relapse | / | 3(1) |
Abbreviations: GVHD, graft-versus-host disease; aGVHD, acute GVHD; cGVHD, chronic GVHD; EBV, Epstein–Barr virus; CMV, cytomegalovirus; BKV, BK virus; TB, tuberculosis; PCP, Pneumocystis carinii pneumonia.